Hospira, Inc. (JOBS) Gains Global Biogeneric Rights from Teva Pharmaceutical Industries Limited (JOBS)

Bookmark and Share

Reuters -- Hospital products and generic drugmaker Hospira Inc said on Wednesday it acquired worldwide rights to a generic version of the white blood-cell boosting drug filgrastim from Teva Pharmaceutical Industries Ltd (TEVA.TA).

MORE ON THIS TOPIC